Industry News from Conferencing

[January 24, 2013]

MPEG LA® Licensing Model Featured at Conference on Food Security

DENVER --(Business Wire)--

World one-stop patent licensing leader MPEG LA discussed its
"many-to-many" licensing model, at a conference on Food Security last
week, as providing for open licensing access to intellectual property
owned by many parties on terms that make the benefits of innovation
available to everyone. The #AccessIP conference, held in Geneva,
Switzerland, was sponsored by Syngenta Corporation to explore the power
of open intellectual property systems and collaborative innovation
models to expand, and facilitate wide access to, new technologies for
feeding the world's population with sufficient, safe and nutritious food.

"Helping tackle critical challenges to advance the world's most
important goals is not beyond the reach of this licensing model," said
MPEG LA President and CEO Larry Horn. "We created a new pro-competitive
form of access to intellectual property rights that balances social
enefit with incentives for patent owners, revolutionizing the way
inventors and users think about intellectual property. What MPEG LA did
to make emerging information technologies available to everyone, it is
now doing with diagnostic tests for personalized medical solutions and
can do for other technologies."

In his presentation, Horn highlighted the role the MPEG LA®
Licensing Model played in enabling users to address the patent thicket
around the MPEG-2 video compression standard. MPEG-2 became the most
successful standard in consumer electronics history producing nearly $4
trillion in worldwide product sales, and the solution pioneered by MPEG
LA became the template for making intellectual property rights around
patent thickets available and affordable to everyone. Today MPEG LA
manages licensing programs consisting of some 8,000 patents in 74
countries with more than 160 patent holders and nearly 6,000 licensees.
MPEG LA's most recent initiative is Librassay®, a web-based
store of biomarker and research tool patent rights from the world's
leading life sciences research institutions in support of tests and
assays, kits, tools and instruments for genetic analysis, biomarker
detection, medical diagnosis, research and drug discovery.